These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38944709)

  • 21. Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.
    Yuen MF
    Hepatol Int; 2015 Jul; 9(3):373-7. PubMed ID: 25788180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic implications of granulocyte colony stimulating factor in patients with acute-on-chronic liver failure: increased survival and containment of liver damage.
    Saha BK; Mahtab MA; Akbar SMF; Noor-E-Alam SM; Mamun AA; Hossain SMS; Alam MA; Moben AL; Khondaker FA; Chowdhury FI; Raihan R; Rahman S; Choudhury AK;
    Hepatol Int; 2017 Nov; 11(6):540-546. PubMed ID: 28840583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The 48-week safety and therapeutic effects of tenofovir alafenamide in hbv-related acute-on-chronic liver failure: A prospective cohort study.
    Zhang Y; Xu W; Zhu X; Li X; Li J; Shu X; Lai J; Xie J; Xie C; Peng L
    J Viral Hepat; 2021 Apr; 28(4):592-600. PubMed ID: 33423348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Switching to tenofovir vs continuing entecavir for hepatitis B virus with partial virologic response to entecavir: a randomized controlled trial.
    Yim HJ; Kim IH; Suh SJ; Jung YK; Kim JH; Seo YS; Yeon JE; Kim CW; Kwon SY; Park SH; Lee MS; Um SH; Byun KS
    J Viral Hepat; 2018 Nov; 25(11):1321-1330. PubMed ID: 29772084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: meta-analysis.
    Ye XG; Su QM
    World J Gastroenterol; 2013 Oct; 19(39):6665-78. PubMed ID: 24151397
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
    Karlas T; Hartmann J; Weimann A; Maier M; Bartels M; Jonas S; Mössner J; Berg T; Tillmann HL; Wiegand J
    Transpl Infect Dis; 2011 Jun; 13(3):299-302. PubMed ID: 21159112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. De novo combined lamivudine and adefovir dipivoxil therapy vs entecavir monotherapy for hepatitis B virus-related decompensated cirrhosis.
    Lian JS; Zeng LY; Chen JY; Jia HY; Zhang YM; Xiang DR; Yu L; Hu JH; Lu YF; Zheng L; Li LJ; Yang YD
    World J Gastroenterol; 2013 Oct; 19(37):6278-83. PubMed ID: 24115827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Superiority of tenofovir alafenamide fumarate over entecavir for serum HBsAg level reduction in patients with chronic HBV infection: A 144-week outcome study after switching of the nucleos(t)ide analog.
    Uchida Y; Nakao M; Yamada S; Tsuji S; Uemura H; Kouyama JI; Naiki K; Sugawara K; Nakayama N; Imai Y; Tomiya T; Mochida S
    PLoS One; 2022; 17(2):e0262764. PubMed ID: 35180213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [To investigate the opportunity of entecavir treatment for HBeAg-negative acute-on-chronic liver].
    Mai L; Yan Y; Zhang SQ; Ke WM; Cao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):286-8. PubMed ID: 24579477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir.
    Brancaccio G; Fasano M; Grossi A; Santantonio TA; Gaeta GB
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1071-1076. PubMed ID: 30793345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the efficacy of tenofovir and entecavir for the treatment of nucleos(t)ide-naive patients with chronic hepatitis B.
    Doğan ÜB; Kara B; Gümürdülü Y; Soylu A; Akin MS
    Turk J Gastroenterol; 2012 Jun; 23(3):247-52. PubMed ID: 22798114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of tenofovir and telbivudine in treatment of hepatitis B related acute on chronic liver failure.
    Malakar D; Mahtab MA; Manik AH; Alam SMNE; Das DC; Mamun AA; Khan MSI; Rahman Z; Rahman S; Akbar SMF
    J Family Med Prim Care; 2021 Jun; 10(6):2381-2385. PubMed ID: 34322442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
    Lee S; Ahn SH; Jung KS; Kim DY; Kim BK; Kim SU; Baatarkhuu O; Ku HJ; Han K; Park JY
    J Viral Hepat; 2017 Feb; 24(2):141-147. PubMed ID: 27766731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure.
    Yue-Meng W; Yang LH; Yang JH; Xu Y; Yang J; Song GB
    Hepatol Int; 2016 May; 10(3):462-9. PubMed ID: 26482576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure.
    Chen T; He Y; Liu X; Yan Z; Wang K; Liu H; Zhang S; Zhao Y
    Clin Exp Med; 2012 Sep; 12(3):159-64. PubMed ID: 22002708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis B relapse after entecavir or tenofovir alafenamide cessation under anti-viral prophylaxis for cancer chemotherapy.
    Fang HW; Tseng PL; Hu TH; Wang JH; Hung CH; Lu SN; Chen CH
    Virol J; 2024 Apr; 21(1):79. PubMed ID: 38570803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of CTP combined with ABIC score in predicting the short-term prognosis of patients with hepatitis B virus-related acute-on-chronic liver failure].
    Cao D; Li DJ; Wang Y; Zhang YH; Chen LY; Wang LC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):118-122. PubMed ID: 30818916
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    Mantzoukis K; Rodríguez-Perálvarez M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011645. PubMed ID: 28321877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Dynamic Model for Predicting Outcome in Patients with HBV Related Acute-On-Chronic Liver Failure.
    Lin W; Zhang J; Liu X; Liu H; He J; Li M; Zhang S; Zhang Y; Chen H; Zhang C; Wu W; Jin C; Lee SS; Duan Z
    Ann Hepatol; 2018; 17(3):392-402. PubMed ID: 29735787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis.
    Xu Y; Zhang YG; Wang X; Qi WQ; Qin SY; Liu ZH; Jiao J; Wang JB
    World J Gastroenterol; 2015 Jul; 21(25):7869-76. PubMed ID: 26167087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.